- call +1-201-465-4211
- email sales@mrinsights.biz
The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
Scope of the Report:
This report focuses on the Active Pharmaceutical Ingredients in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to cut costs.
This has caused significant changes to how these drugs are regulated, with more rigorous guidelines and inspections put into place.
The worldwide market for Active Pharmaceutical Ingredients is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Merck
Novartis
Pfizer
Roche
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
Abbott Laboratories
Emcure Pharmaceuticals
Ipca Laboratories
Johnson Matthey
Guilin Pharmaceutical
Johnson & Johnson
Lonza Group
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Synthetic
Biotech
Market Segment by Applications, can be divided into
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
There are 15 Chapters to deeply display the global Active Pharmaceutical Ingredients market.
Chapter 1, to describe Active Pharmaceutical Ingredients Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Active Pharmaceutical Ingredients, with sales, revenue, and price of Active Pharmaceutical Ingredients, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Active Pharmaceutical Ingredients, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Active Pharmaceutical Ingredients market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Active Pharmaceutical Ingredients sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Active Pharmaceutical Ingredients Introduction
1.2 Market Analysis by Type
1.2.1 Synthetic
1.2.2 Biotech
1.3 Market Analysis by Applications
1.3.1 Diagnostic Laboratories
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Active Pharmaceutical Ingredients Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Active Pharmaceutical Ingredients Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Active Pharmaceutical Ingredients Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche
2.4.1 Business Overview
2.4.2 Active Pharmaceutical Ingredients Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sun Pharmaceutical Industries
2.5.1 Business Overview
2.5.2 Active Pharmaceutical Ingredients Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva Pharmaceutical Industries
2.6.1 Business Overview
2.6.2 Active Pharmaceutical Ingredients Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Pharmaceutical Industries Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Abbott Laboratories
2.7.1 Business Overview
2.7.2 Active Pharmaceutical Ingredients Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbott Laboratories Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Emcure Pharmaceuticals
2.8.1 Business Overview
2.8.2 Active Pharmaceutical Ingredients Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Emcure Pharmaceuticals Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ipca Laboratories
2.9.1 Business Overview
2.9.2 Active Pharmaceutical Ingredients Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ipca Laboratories Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Johnson Matthey
2.10.1 Business Overview
2.10.2 Active Pharmaceutical Ingredients Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson Matthey Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Guilin Pharmaceutical
2.11.1 Business Overview
2.11.2 Active Pharmaceutical Ingredients Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Guilin Pharmaceutical Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Johnson & Johnson
2.12.1 Business Overview
2.12.2 Active Pharmaceutical Ingredients Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Johnson & Johnson Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Lonza Group
2.13.1 Business Overview
2.13.2 Active Pharmaceutical Ingredients Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Lonza Group Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Active Pharmaceutical Ingredients Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Active Pharmaceutical Ingredients Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Active Pharmaceutical Ingredients Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Active Pharmaceutical Ingredients Manufacturer Market Share in 2017
3.3.2 Top 6 Active Pharmaceutical Ingredients Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Active Pharmaceutical Ingredients Market Analysis by Regions
4.1 Global Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Regions
4.1.1 Global Active Pharmaceutical Ingredients Sales and Market Share by Regions (2013-2018)
4.1.2 Global Active Pharmaceutical Ingredients Revenue and Market Share by Regions (2013-2018)
4.2 North America Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
4.3 Europe Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
4.5 South America Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
5 North America Active Pharmaceutical Ingredients by Countries
5.1 North America Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Countries
5.1.1 North America Active Pharmaceutical Ingredients Sales and Market Share by Countries (2013-2018)
5.1.2 North America Active Pharmaceutical Ingredients Revenue and Market Share by Countries (2013-2018)
5.2 United States Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
5.3 Canada Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
5.4 Mexico Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
6 Europe Active Pharmaceutical Ingredients by Countries
6.1 Europe Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Countries
6.1.1 Europe Active Pharmaceutical Ingredients Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Active Pharmaceutical Ingredients Revenue and Market Share by Countries (2013-2018)
6.2 Germany Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
6.3 UK Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
6.4 France Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
6.5 Russia Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
6.6 Italy Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
7 Asia-Pacific Active Pharmaceutical Ingredients by Countries
7.1 Asia-Pacific Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Active Pharmaceutical Ingredients Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Active Pharmaceutical Ingredients Revenue and Market Share by Countries (2013-2018)
7.2 China Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
7.3 Japan Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
7.4 Korea Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
7.5 India Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
8 South America Active Pharmaceutical Ingredients by Countries
8.1 South America Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Countries
8.1.1 South America Active Pharmaceutical Ingredients Sales and Market Share by Countries (2013-2018)
8.1.2 South America Active Pharmaceutical Ingredients Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
8.3 Argentina Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
8.4 Colombia Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
9 Middle East and Africa Active Pharmaceutical Ingredients by Countries
9.1 Middle East and Africa Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Active Pharmaceutical Ingredients Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Active Pharmaceutical Ingredients Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
9.3 UAE Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
9.4 Egypt Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
9.5 Nigeria Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
9.6 South Africa Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
10 Global Active Pharmaceutical Ingredients Market Segment by Type
10.1 Global Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Active Pharmaceutical Ingredients Sales and Market Share by Type (2013-2018)
10.1.2 Global Active Pharmaceutical Ingredients Revenue and Market Share by Type (2013-2018)
10.2 Synthetic Sales Growth and Price
10.2.1 Global Synthetic Sales Growth (2013-2018)
10.2.2 Global Synthetic Price (2013-2018)
10.3 Biotech Sales Growth and Price
10.3.1 Global Biotech Sales Growth (2013-2018)
10.3.2 Global Biotech Price (2013-2018)
11 Global Active Pharmaceutical Ingredients Market Segment by Application
11.1 Global Active Pharmaceutical Ingredients Sales Market Share by Application (2013-2018)
11.2 Diagnostic Laboratories Sales Growth (2013-2018)
11.3 Research & Academic Laboratories Sales Growth (2013-2018)
11.4 Pharmaceutical & Biotechnology Companies Sales Growth (2013-2018)
12 Active Pharmaceutical Ingredients Market Forecast (2018-2023)
12.1 Global Active Pharmaceutical Ingredients Sales, Revenue and Growth Rate (2018-2023)
12.2 Active Pharmaceutical Ingredients Market Forecast by Regions (2018-2023)
12.2.1 North America Active Pharmaceutical Ingredients Market Forecast (2018-2023)
12.2.2 Europe Active Pharmaceutical Ingredients Market Forecast (2018-2023)
12.2.3 Asia-Pacific Active Pharmaceutical Ingredients Market Forecast (2018-2023)
12.2.4 South America Active Pharmaceutical Ingredients Market Forecast (2018-2023)
12.2.5 Middle East and Africa Active Pharmaceutical Ingredients Market Forecast (2018-2023)
12.3 Active Pharmaceutical Ingredients Market Forecast by Type (2018-2023)
12.3.1 Global Active Pharmaceutical Ingredients Sales Forecast by Type (2018-2023)
12.3.2 Global Active Pharmaceutical Ingredients Market Share Forecast by Type (2018-2023)
12.4 Active Pharmaceutical Ingredients Market Forecast by Application (2018-2023)
12.4.1 Global Active Pharmaceutical Ingredients Sales Forecast by Application (2018-2023)
12.4.2 Global Active Pharmaceutical Ingredients Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Active Pharmaceutical Ingredients Picture
Table Product Specifications of Active Pharmaceutical Ingredients
Figure Global Sales Market Share of Active Pharmaceutical
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
